Hungarian research institute spanning drug discovery, biosensors, energy storage modelling, and neuroscience — a versatile specialist contributor in European consortia.
HUN-REN Research Centre for Natural Sciences is Hungary's premier multidisciplinary research institute, operating across chemistry, biology, and materials science. Their teams contribute specialized experimental and computational capabilities to European consortia — from designing allosteric drug inhibitors and screening small molecules, to developing biosensors for food safety and modelling next-generation flow batteries. They are a training-intensive institution, frequently hosting early-stage researchers through Marie Skłodowska-Curie networks, and serve as a node in pan-European research infrastructures like ELIXIR and EU-OPENSCREEN.
FRAGNET (fragment-based drug design training network), ALLODD (allosteric drug discovery), EU-OPENSCREEN-DRIVE (chemical biology screening infrastructure), and BARREL (membrane-active foldamers) form a consistent thread in molecular design.
FORMILK and SAFEMILK both focus on innovative detection technologies for milk safety using biosensors, aptamers, and electrochemistry.
FlowCamp (redox-flow battery materials training network) and CompBat (computational design for flow batteries) show sustained work in energy storage modelling and materials.
ChildBrain and Neo-PRISM-C both address neurodevelopmental disorders in children using multi-modal brain imaging (EEG, MEG, MRI).
ELIXIR-CONVERGE (FAIR life-science data services) and EU-OPENSCREEN-DRIVE (chemical biology infrastructure sustainability) position them as a node in European research infrastructure networks.
In the early period (2015–2018), the centre's H2020 work was anchored in energy storage materials — redox-flow batteries, hydrogen-bromine systems, and novel membranes — alongside foundational chemistry projects like membrane-active foldamers and fragment-based drug design. From 2019 onward, the focus shifted decisively toward life sciences: child neurodevelopment, allosteric drug discovery, milk safety biosensors, and participation in pan-European research infrastructure networks (ELIXIR, EU-OPENSCREEN). The computational modelling expertise carried over, but the application domain moved from batteries to biological systems and drug design.
They are consolidating around drug discovery, biosensing, and research infrastructure roles — expect future proposals in computational pharmacology, FAIR data for chemical biology, and translational biosensor applications.
Overwhelmingly a participant rather than a leader — they coordinated just one small MSCA fellowship (BARREL, EUR 146K) out of 13 projects. With 218 unique partners across 33 countries, they integrate into large, diverse consortia rather than leading them, contributing specialized experimental or computational capabilities to broader networks. This makes them a reliable, low-friction partner who brings deep domain expertise without competing for coordination roles.
Exceptionally broad network for their project count: 218 unique partners across 33 countries, driven by participation in large Marie Curie training networks and infrastructure projects. Their reach is truly pan-European with no strong geographic clustering beyond natural ties to Central European institutions.
What sets HUN-REN TTK apart is their genuine multidisciplinarity — few single institutes span flow battery modelling, allosteric drug design, neuroscience imaging, and food safety biosensors with demonstrated project track records in each. For consortium builders, they offer a rare combination: strong computational and experimental chemistry capabilities housed in a single institution, with the flexibility to contribute across life sciences and energy. Their MSCA track record also makes them a strong candidate for training and mobility components in proposals.
